JP2022523372A5 - - Google Patents
Info
- Publication number
- JP2022523372A5 JP2022523372A5 JP2021549416A JP2021549416A JP2022523372A5 JP 2022523372 A5 JP2022523372 A5 JP 2022523372A5 JP 2021549416 A JP2021549416 A JP 2021549416A JP 2021549416 A JP2021549416 A JP 2021549416A JP 2022523372 A5 JP2022523372 A5 JP 2022523372A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- pharmaceutical composition
- seq
- approximately
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025034340A JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809070P | 2019-02-22 | 2019-02-22 | |
| US62/809,070 | 2019-02-22 | ||
| US201962829791P | 2019-04-05 | 2019-04-05 | |
| US201962829814P | 2019-04-05 | 2019-04-05 | |
| US201962829804P | 2019-04-05 | 2019-04-05 | |
| US62/829,814 | 2019-04-05 | ||
| US62/829,791 | 2019-04-05 | ||
| US62/829,804 | 2019-04-05 | ||
| PCT/IB2020/051484 WO2020170211A1 (en) | 2019-02-22 | 2020-02-21 | Methods of treating newly diagnosed multiple myeloma with a combination of an antibody that specifically binds cd38, lenalidomide and dexamethasone |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034340A Division JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523372A JP2022523372A (ja) | 2022-04-22 |
| JP2022523372A5 true JP2022523372A5 (https=) | 2023-06-27 |
| JP7721445B2 JP7721445B2 (ja) | 2025-08-12 |
Family
ID=72141407
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549416A Active JP7721445B2 (ja) | 2019-02-22 | 2020-02-21 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
| JP2025034340A Pending JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034340A Pending JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200268847A1 (https=) |
| EP (1) | EP3927376A4 (https=) |
| JP (2) | JP7721445B2 (https=) |
| CN (1) | CN113727729A (https=) |
| CA (1) | CA3131064A1 (https=) |
| WO (1) | WO2020170211A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| CN107406506A (zh) | 2014-12-04 | 2017-11-28 | 詹森生物科技公司 | 用于治疗急性髓系白血病的抗cd38抗体 |
| EA201792546A1 (ru) | 2015-05-20 | 2018-04-30 | Янссен Байотек, Инк. | Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей |
| CA3004152C (en) | 2015-11-03 | 2024-04-16 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-cd38 antibodies and their uses |
| US20190233533A1 (en) | 2016-06-28 | 2019-08-01 | Umc Utrecht Holding B.V. | Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38 |
| MA50514A (fr) | 2017-10-31 | 2020-09-09 | Janssen Biotech Inc | Méthodes de traitement du myélome multiple à haut risque |
| WO2023209555A1 (en) | 2022-04-26 | 2023-11-02 | Aragon Pharmaceuticals, Inc. | Approved drug products and methods for treating prostate cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9732154B2 (en) * | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| KR20170020371A (ko) * | 2014-06-16 | 2017-02-22 | 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 | 골수종의 치료 |
| WO2016022589A2 (en) * | 2014-08-08 | 2016-02-11 | The Regents Of The University Of California | Methods for treating multiple myeloma |
| US20170044265A1 (en) * | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
-
2020
- 2020-02-21 WO PCT/IB2020/051484 patent/WO2020170211A1/en not_active Ceased
- 2020-02-21 US US16/797,301 patent/US20200268847A1/en active Pending
- 2020-02-21 CN CN202080015963.2A patent/CN113727729A/zh active Pending
- 2020-02-21 CA CA3131064A patent/CA3131064A1/en active Pending
- 2020-02-21 JP JP2021549416A patent/JP7721445B2/ja active Active
- 2020-02-21 EP EP20759735.2A patent/EP3927376A4/en active Pending
-
2025
- 2025-03-05 JP JP2025034340A patent/JP2025102775A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523372A5 (https=) | ||
| JP2025102775A5 (https=) | ||
| CN119679936A (zh) | 针对靶向b细胞成熟抗原的多特异性抗体的给药方案和组合疗法 | |
| JP2017048208A5 (https=) | ||
| JP2021532126A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| JP2013542194A5 (https=) | ||
| JP2023545520A5 (https=) | ||
| JP2017514461A5 (https=) | ||
| JP2013542191A5 (https=) | ||
| RU2016130056A (ru) | Способы лечения кожной инфекции путем введения антагониста il-4r | |
| JP2024540054A5 (https=) | ||
| JP2015530399A5 (https=) | ||
| JP2018535648A5 (https=) | ||
| RU2019112029A (ru) | Применение комбинации антитела к pd-1 и ингибитора vegfr в изготовлении лекарственного средства для лечения злокачественных новообразований | |
| JP2022515077A5 (https=) | ||
| TW202311284A (zh) | 抗金黃色葡萄球菌溶血素ａ毒素之人類抗體 | |
| JP2018505882A5 (https=) | ||
| JP2022532927A5 (https=) | ||
| JP2022512851A5 (https=) | ||
| JP2015500822A5 (https=) | ||
| JP2024533067A5 (https=) | ||
| RU2017137496A (ru) | Средство для лечения множественной миеломы (ММ) | |
| JP2022532356A5 (https=) | ||
| JP2024515968A5 (https=) |